Table 1. Cohort characteristics . All .... | American Society of Hematology

Table 1.

Cohort characteristics

	All	White	African American
Number of patients	1889	1158	551
Age at multiple myeloma diagnosis, mean ± SD, y*	68.9 ± 10.2	70.3 ± 10.0	66.2 ± 9.9
Female sex, %	3.2	2.8	4.1
International Staging System stage†	I, II, III:18.3%, 30.2%, 51.5%	I, II, III:15.6%, 32.5%, 51.9%	I, II, III:24.0%, 25.3%, 50.6%
Vitamin D level, median/mean	26.5/29.2	28.6/31.3	21.5/24.6
Vitamin D level <20, %*	30.9	23.6	46.3

	All	White	African American
Number of patients	1889	1158	551
Age at multiple myeloma diagnosis, mean ± SD, y*	68.9 ± 10.2	70.3 ± 10.0	66.2 ± 9.9
Female sex, %	3.2	2.8	4.1
International Staging System stage†	I, II, III:18.3%, 30.2%, 51.5%	I, II, III:15.6%, 32.5%, 51.9%	I, II, III:24.0%, 25.3%, 50.6%
Vitamin D level, median/mean	26.5/29.2	28.6/31.3	21.5/24.6
Vitamin D level <20, %*	30.9	23.6	46.3

Significant difference between race groups P < .001.

Significant difference between race groups P < .05.